Discovery of benzimidazole derivatives as orally active renin inhibitors: Optimization of 3,5-disubstituted piperidine to improve pharmacokinetic profile

Bioorganic & Medicinal Chemistry
Hidekazu TokuharaTakanobu Kuroita

Abstract

We previously identified 2-tert-butyl-4-[(3-methoxypropyl)amino]-N-(2-methylpropyl)-N-[(3S,5R)-5-(morpholin-4-ylcarbonyl)piperidin-3-yl]pyrimidine-5-carboxamide 3 as a potent renin inhibitor. Since 3 showed unacceptably low bioavailability (BA) in rats, structural modification, using SBDD and focused on physicochemical properties was conducted to improve its PK profile while maintaining renin inhibitory activity. Conversion of the amino group attached at the 4-position of pyrimidine to methylene group improved PK profile and decreased renin inhibitory activity. New central cores with carbon side chains were explored to improve potency. We had designed a series of 5-membered azoles and fused heterocycles that interacted with the lipophilic S3 pocket. In the course of modification, renin inhibitory activity was enhanced by the formation of an additional hydrogen bonding with the hydroxyl group of Thr77. Consequently, a series of novel benzimidazole derivatives were discovered as potent and orally bioavailable renin inhibitors. Among those, compound 13 exhibited more than five-fold of plasma renin inhibition than aliskiren in cynomolgus monkeys at dose ratio.

References

Jan 1, 1978·Annual Review of Physiology·I A ReidW F Ganong
Oct 1, 1990·Physiological Reviews·E HackenthalR Taugner
Jan 1, 1985·Journal of Cardiovascular Pharmacology·H R BrunnerB Waeber
Jan 1, 1987·Journal of Enzyme Inhibition·J M WoodK G Hofbauer
Jun 20, 1996·The New England Journal of Medicine·T L GoodfriendK J Catt
Feb 28, 2001·Expert Opinion on Investigational Drugs·N D Fisher, N K Hollenberg
May 3, 2002·Journal of Human Hypertension·R Hernández-HernándezR Cammarata
May 31, 2002·Journal of Medicinal Chemistry·Daniel F VeberKenneth D Kopple
Apr 15, 2003·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Alice Stanton
Apr 30, 2003·Journal of Structural Biology·David HosfieldRaymond C Stevens
Sep 1, 1957·The Journal of Experimental Medicine·L T SKEGGSN P SHUMWAY
Nov 5, 2003·Journal of Hypertension·Judith A Whitworth, UNKNOWN World Health Organization, International Society of Hypertension Writing Group
Dec 31, 2003·Methods in Enzymology·Martyn D WinnMiroslav Z Papiz
Feb 11, 2005·Journal of the American Society of Nephrology : JASN·Naomi D L Fisher, Norman K Hollenberg
Jul 2, 2005·The American Journal of Medicine·William B White
Jun 6, 2008·The New England Journal of Medicine·Hans-Henrik ParvingUNKNOWN AVOID Study Investigators
Jul 10, 2008·Clinical Pharmacokinetics·Sujata VaidyanathanWilliam P Dole
Nov 26, 2009·Nature Reviews. Nephrology·Norman K Hollenberg
May 22, 2010·Cardiovascular Drugs and Therapy·Christian W Mende
Aug 25, 2010·Journal of Medicinal Chemistry·Randy L WebbJürgen Maibaum
Dec 3, 2013·Chemical & Pharmaceutical Bulletin·Shoko NakashimaYukihiro Ikeda
Oct 26, 2016·Bioorganic & Medicinal Chemistry·Yasuhiro ImaedaTakanobu Kuroita
Oct 25, 2016·ACS Medicinal Chemistry Letters·Yasuhiro ImaedaTakanobu Kuroita
Jan 1, 1997·Methods in Enzymology·Zbyszek Otwinowski, Wladek Minor

❮ Previous
Next ❯

Citations

May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anton BudeevMikhail Krasavin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.